Chiome Bioscience Company
Chiome Bioscience is to commercialize the innovative ADLib'antibody generation technology invented at RIKEN.
Connections
Founded Date:
2005
Headquarters:
Tokyo, Tokyo, Japan
Technology:
Others
Employee Number:
11-50
Industry:
PharmTech
Funding Status:
IPO